Status:

COMPLETED

Breathing Exercise for Chronic Pain Management in Breast Cancer Survivors

Lead Sponsor:

Charles Darwin University

Collaborating Sponsors:

The Affiliated Hospital Of Southwest Medical University

Conditions:

Chronic Pain

Breast Neoplasms

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

The study will follow the MRC Framework to develop an evidence-based BE intervention protocol to help breast cancer survivors with better management of cancer-related chronic pain.

Detailed Description

Cancer-related chronic pain remains as a big challenge for cancer survivors, which significantly affects the quality of life of cancer survivors. Evidence suggests that pain is well managed through co...

Eligibility Criteria

Inclusion

  • female breast cancer survivors ≥18 years age;
  • has a confirmed diagnosis of breast cancer at stage I, II or IIIa;
  • has been experiencing pain since cancer diagnosis constantly or intermittently for ≥3 months, with the average pain intensity in the last seven days on a numerical scale ≥4/10 ("0" indicates no pain and "10" indicates the worst pain);
  • has completed active anticancer treatment (such as chemotherapy, radiotherapy, surgery) for at least three months;
  • agrees to participate in the research and is willing to give informed consent;
  • can read and understand Mandarin Chinese.

Exclusion

  • extremely weak and unable to perform the breathing exercises;
  • mentally incapable (i.e., unable to follow the study instructions);
  • has scheduled pain management interventions, such as having a procedure or operation;
  • receiving other pain relief treatments, such as acupuncture, yoga, qigong, exercise program, etc.;
  • has any pre-existing chronic pain conditions before cancer diagnosis, such as arthritis, rheumatoid arthritis, chronic low back pain, migraines, trigeminal neuralgia, fibromyalgia, joint dysfunction, Complex Regional Pain Syndrome, endometriosis, etc.

Key Trial Info

Start Date :

January 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 12 2023

Estimated Enrollment :

72 Patients enrolled

Trial Details

Trial ID

NCT05257876

Start Date

January 1 2023

End Date

August 12 2023

Last Update

February 16 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Affiliated Hospital Of Southwest Medical University

Luzhou, Sichuan, China, 646000